Literature DB >> 18329371

Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage.

Sergei B Koralov1, Stefan A Muljo, Gunther R Galler, Azra Krek, Tirtha Chakraborty, Chryssa Kanellopoulou, Kari Jensen, Bradley S Cobb, Matthias Merkenschlager, Nikolaus Rajewsky, Klaus Rajewsky.   

Abstract

To explore the role of Dicer-dependent control mechanisms in B lymphocyte development, we ablated this enzyme in early B cell progenitors. This resulted in a developmental block at the pro- to pre-B cell transition. Gene-expression profiling revealed a miR-17 approximately 92 signature in the 3'UTRs of genes upregulated in Dicer-deficient pro-B cells; a top miR-17 approximately 92 target, the proapoptotic molecule Bim, was highly upregulated. Accordingly, B cell development could be partially rescued by ablation of Bim or transgenic expression of the prosurvival protein Bcl-2. This allowed us to assess the impact of Dicer deficiency on the V(D)J recombination program in developing B cells. We found intact Ig gene rearrangements in immunoglobulin heavy (IgH) and kappa chain loci, but increased sterile transcription and usage of D(H) elements of the DSP family in IgH, and increased N sequence addition in Igkappa due to deregulated transcription of the terminal deoxynucleotidyl transferase gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18329371     DOI: 10.1016/j.cell.2008.02.020

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  278 in total

1.  Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.

Authors:  Clayton A White; Egest J Pone; Tonika Lam; Connie Tat; Ken L Hayama; Guideng Li; Hong Zan; Paolo Casali
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

2.  Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk.

Authors:  Moshe Biton; Avi Levin; Michal Slyper; Irit Alkalay; Elad Horwitz; Hagar Mor; Sharon Kredo-Russo; Tali Avnit-Sagi; Gady Cojocaru; Farid Zreik; Zvi Bentwich; Matthew N Poy; David Artis; Michael D Walker; Eran Hornstein; Eli Pikarsky; Yinon Ben-Neriah
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

Review 3.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

4.  Loss of microRNAs in thymus perturbs invariant NKT cell development and function.

Authors:  Kook-Heon Seo; Li Zhou; Dongmei Meng; Jianrui Xu; Zhong Dong; Qing-Sheng Mi
Journal:  Cell Mol Immunol       Date:  2010-09-20       Impact factor: 11.530

5.  MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output.

Authors:  Ryan M O'Connell; Aadel A Chaudhuri; Dinesh S Rao; William S J Gibson; Alejandro B Balazs; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

6.  Myogenic microRNA expression requires ATP-dependent chromatin remodeling enzyme function.

Authors:  Chandrashekara Mallappa; Brian T Nasipak; Letitiah Etheridge; Elliot J Androphy; Stephen N Jones; Charles G Sagerström; Yasuyuki Ohkawa; Anthony N Imbalzano
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

Review 7.  microRNAs: critical regulators in Th17 cells and players in diseases.

Authors:  Bin Wei; Gang Pei
Journal:  Cell Mol Immunol       Date:  2010-04-05       Impact factor: 11.530

Review 8.  miRNAs in normal and malignant B cells.

Authors:  Ai Kotani; Ratanakanit Harnprasopwat; Takae Toyoshima; Toyotaka Kawamata; Arinobu Tojo
Journal:  Int J Hematol       Date:  2010-07-08       Impact factor: 2.490

9.  Dicer controls CD8+ T-cell activation, migration, and survival.

Authors:  Nu Zhang; Michael J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

Review 10.  The microRNA-17-92 family of microRNA clusters in development and disease.

Authors:  Carla P Concepcion; Ciro Bonetti; Andrea Ventura
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.